CHARLOTTESVILLE, Va. – Caretaker Medical has received CE Mark for its Caretaker4 wireless CNIBP vital signs monitor for continuous non-invasive blood pressure and vital signs monitoring. The CE Mark registration will allow the company to expand its global sales and distribution efforts. The Caretaker4 is able to measure continuous blood pressure and vital signs without external arm cuffs and to send patient data to other monitoring platforms. “The Caretaker4 wearable vital signs device sets a new standard in monitoring patients’ continuous blood pressure and vital signs, either in hospital or remote monitoring situations,” said Warren Kressinger-Dunn, managing director, EMEA–APAC, at Caretaker Medical, in a statement.
BOSTON – Vital USA has teamed up with Partners Connected Health Care on a clinical trial to validate Vital’s 5-in-1 integrated vital sign monitoring platform. Paired with a smartphone, the Vital Moto Mod platform works with the Vital app to measure, monitor and track heart rate, respiratory rate, oxygen saturation, non-contact core body temperature and blood pressure, all within three minutes. “We have learned that frictionless technologies for biometric data collection from patients is key in fostering their engagement with digital products,” said Dr. Kamal Jethwani, senior director at Partners Connected Health Innovation, in a statement. “This product streamlines the vitals measurement process, replacing five discreet devices with one, and we are going to validate that this product is changing digital vitals collection from patients.” Using light and pressure sensors, Vital’s proprietary finger cuff measures systolic and diastolic blood pressure from the finger. The system captures user data wirelessly and uploads the data via Bluetooth to the cloud securely. “This is really the next frontier for personal wellness,” said Dr. Mark Blatt, chief medical officer at Vital USA, in a statement. “By providing the consumer with a simple way to measure and monitor the five critical vital health signs, they are empowered to take control, and keep an eye on their own overall health and wellness.”
ITHACA, NY – Scientists at Cornell University have developed a method for gathering vital signs with “tag” devices that use radar-like technology.
“If this is an emergency room, everybody that comes in can wear these tags or can simply put tags in their front pockets, and everybody’s vital signs can be monitored at the same time,” said Edwin Kan, who developed the tag system, in a statement. “I’ll know exactly which person each of the vital signs belongs to.”
The system of radio-frequency signals and microchip tags can gather blood pressure, heart rate and breath rate by emitting radio waves that bounce off the body and internal organs and are then detected by an electronic reader that gathers the data from a location elsewhere in the room.
Kan said the system works like radar but integrates near-field coherent sensing, which is better at directing electromagnetic signals into body tissue, allowing the tags to measure internal body movement such as a heart as it beats or blood as it pulses under skin. Because each tag has a unique identification code it transmits with its signal, up to 200 people can be monitored simultaneously using just one central reader.
The signal is as accurate as an electrocardiogram or a blood-pressure cuff and could also be used to measure bowel movement, eye movement and other internal mechanical motions produced by the body, Kan said.
Kan’s research team is also working with Cornell’s Department of Fiber Science and Apparel Design, who have demonstrated a way to embroider the tags directly onto clothing using fibers coated with nanoparticles.
‘This is an IoT device if there ever was one’
PLANO, Texas – The SensoSCAN vital sign monitor from Sensogram Technologies is in the final phases of development and is ready to shake up the market later this month.
SensoSCAN is a continuous, non-invasive, wireless, integrated vital sign monitor for the assisted living, PERS, elderly remote patient monitoring and home wellness markets. Sensogram will launch a fall detection wristband in April, followed by a ring that monitors an exhaustive list of vital signs by mid-year.
“SensoSCAN is a better tool to take patient monitoring to the next level,” said Pete Ianace, Sensogram corporate development director. “From a pure market perspective, this is an Internet of Things, big data device if there ever was one.”
SensoSCAN monitors blood pressure, respiration, heart rate and oxygen saturation in real time through a single wearable device. Users can monitor and share their vitals with caregivers, family members and physicians through smartphone apps and a website portal.
“We are proud to introduce an easy-to-use, non-invasive wearable device that can continuously monitor blood pressure,” said Dr. Vahram Mouradian, founder and CEO of Sensogram. ” The ability to share real-time vitals data with those with a need to know will help manage known chronic illnesses or even help prevent their onset. This is because the data stream is continuous and not just a spot check done a few times a year with a blood pressure cuff.”
The device collects the data 512 times per second, then filters and stores it for analysis at a later date.
“The data can be used to predict things like a heart attack or stroke, which increases a patient’s chance of survival,” Ianace said.
Sensogram is confident that SensoSCAN will simplify a process that historically has been complicated, improving health care and patient outcomes.
“No one else has been able to do non-invasive, real-time blood pressure monitoring until now,” said Ianace. “This is big data collection at the human level.”
Ianace said the first 30,000 units of SensoSCAN will be pushed to its four targeted markets, then the company will then begin looking at expanding out.
Ianace said Sensogram also plans on licensing the platform to third parties.
“There are big opportunities for telehealth, long-term disease management and post-surgical discharge,” said Ianace.
Ianace said the device should receive approval from the U.S. Food and Drug Administration soon, as well as CE Mark certification.